which glp 1 is best for kidney disease and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials The 5 Best Electrolytes for

Unlike claims datasets often lacking this depth, Truvetas EHR data captures both clinical and prescribing information

Sleep can slip during the early weeks as the body adapts to slower gastric emptying

There are modest improvements in glucose control but perhaps increased rates of hypoglycaemia

A new study has found that when it comes to the neuroprotective abilities of diabetes medications, people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users

I'm Marisha Moyes, a clinical researcher from McGill University

Our results generated from real-world clinical practice aligned with the observations from the above two trials